A 58-year-old man with a 10-year history of rheumatoid arthritis presents with nephrotic syndrome (proteinuria 4.5 g/day, serum albumin 2.8 g/dL) and hepatomegaly. Renal biopsy shows amyloid deposits in the glomeruli. Which finding on immunofluorescence would best distinguish this patient's amyloid type from AL amyloidosis?

Explanation

## Immunofluorescence Microscopy in AA vs AL Amyloidosis ### Clinical Context: Secondary Amyloidosis (AA Type) **Key Point:** This patient has chronic rheumatoid arthritis, a classic risk factor for **secondary (AA) amyloidosis**. The combination of chronic inflammatory disease + nephrotic syndrome + hepatomegaly is the classic triad of AA amyloidosis. ### Why Light Chain Staining Distinguishes the Types | Feature | AL Amyloidosis | AA Amyloidosis | |---------|---|---| | **Amyloid precursor protein** | Misfolded immunoglobulin light chain (κ or λ) | Serum amyloid A (acute-phase reactant) | | **Immunofluorescence for κ light chain** | **Positive** (if κ type) | **Negative** | | **Immunofluorescence for λ light chain** | **Positive** (if λ type) | **Negative** | | **Light chain restriction pattern** | Monoclonal (either κ OR λ, not both) | Neither κ nor λ | | **Plasma cell dyscrasia** | Often present (MGUS, myeloma) | Absent | | **Underlying condition** | Hematologic malignancy | Chronic infection or inflammation | ### Why This Patient Has AA Amyloidosis **Clinical Pearl:** Rheumatoid arthritis is the most common cause of secondary amyloidosis in developed countries. Chronic inflammation drives persistent elevation of serum amyloid A, leading to systemic deposition in kidneys (nephrotic syndrome), liver (hepatomegaly), and spleen. **High-Yield:** On immunofluorescence, AA amyloidosis shows **NO staining for light chains** (neither κ nor λ), because the amyloid fibrils are composed of serum amyloid A protein, not immunoglobulin light chains. This is the definitive discriminator. ### Diagnostic Algorithm ```mermaid flowchart TD A[Amyloidosis confirmed<br/>Congo red + birefringence]:::outcome --> B{Clinical context?}:::decision B -->|Chronic inflammation<br/>RA, TB, IBD|C[Suspect AA amyloidosis]:::action B -->|Plasma cell disorder<br/>MGUS, myeloma|D[Suspect AL amyloidosis]:::action C --> E[Immunofluorescence:<br/>κ and λ staining?]:::decision D --> E E -->|Both negative| F[AA Amyloidosis confirmed]:::outcome E -->|κ or λ positive| G[AL Amyloidosis confirmed]:::outcome F --> H[Manage underlying<br/>inflammation: DMARDs, etc.]:::action G --> I[Chemotherapy, stem cell<br/>transplant, supportive care]:::action ``` **Mnemonic:** **AA = Absent light chains** (remember: **A**A amyloid has **A**bsent κ and λ staining). **AL = Amyloid Light-chain** (remember: **A**L has **A**ctive light chain staining). ### Key Diagnostic Points **Warning:** Do NOT confuse the presence of immunoglobulin deposits (seen in immune complex diseases like lupus or IgA nephropathy) with light chain restriction in amyloidosis. In amyloidosis, light chains are part of the amyloid fibril structure itself, not immune complexes.